BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23990144)

  • 1. SPECT/CT and tumour imaging.
    Abikhzer G; Keidar Z
    Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1():S67-80. PubMed ID: 23990144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation?
    Schillaci O; Danieli R; Manni C; Simonetti G
    Nucl Med Commun; 2004 Jul; 25(7):705-10. PubMed ID: 15208498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions.
    Delbeke D; Schöder H; Martin WH; Wahl RL
    Semin Nucl Med; 2009 Sep; 39(5):308-40. PubMed ID: 19646557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
    Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-photon emission computed tomography/computed tomography in brain tumors.
    Schillaci O; Filippi L; Manni C; Santoni R
    Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging agents for SPECT (and SPECT/CT).
    Gnanasegaran G; Ballinger JR
    Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1():S26-35. PubMed ID: 24318159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid SPECT/CT imaging in neurology.
    Ciarmiello A; Giovannini E; Meniconi M; Cuccurullo V; Gaeta MC
    Curr Radiopharm; 2014; 7(1):5-11. PubMed ID: 25143053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
    Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
    Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid SPECT/CT Imaging in the Management of Differentiated Thyroid Carcinoma.
    Ahmed N; Niyaz K; Borakati A; Marafi F; Birk R; Usmani S
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):303-308. PubMed ID: 29479949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of single-photon emission computed tomography and SPECT/computed tomography in oncologic imaging.
    Brandon D; Alazraki A; Halkar RK; Alazraki NP
    Semin Oncol; 2011 Feb; 38(1):87-108. PubMed ID: 21362518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
    Schillaci O
    Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph nodes and planar scintigraphy and SPECT/CT in various types of tumours. Estimation of some factors influencing detection success.
    Kraft O; Havel M
    Nucl Med Rev Cent East Eur; 2013; 16(1):17-25. PubMed ID: 23677759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hybrid SPECT-CT in oncology: current and emerging clinical applications.
    Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2008 Mar; 63(3):241-51. PubMed ID: 18275863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical SPECT and SPECT-CT in Oncology.
    Franc BL; Seo Y; Flavell R; Aparici CM
    Recent Results Cancer Res; 2020; 216():359-404. PubMed ID: 32594393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added Value of SPECT/CT in the Evaluation of Benign Bone Diseases of the Appendicular Skeleton.
    Abikhzer G; Srour S; Keidar Z; Bar-Shalom R; Kagna O; Israel O; Militianu D
    Clin Nucl Med; 2016 Apr; 41(4):e195-9. PubMed ID: 26545023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation risk and protection of patients in clinical SPECT/CT.
    Brix G; Nekolla EA; Borowski M; Noßke D
    Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1():S125-36. PubMed ID: 24052089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.
    Bernsen MR; Vaissier PE; Van Holen R; Booij J; Beekman FJ; de Jong M
    Eur J Nucl Med Mol Imaging; 2014 May; 41 Suppl 1(Suppl 1):S36-49. PubMed ID: 24895751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The value of multimodal imaging by single photon emission computed tomography associated to X ray computed tomography (SPECT-CT) in the management of differentiated thyroid carcinoma: about 156 cases].
    Mhiri A; El Bez I; Slim I; Meddeb I; Yeddes I; Ghezaiel M; Gritli S; Ben Slimène MF
    Tunis Med; 2013 Oct; 91(10):589-93. PubMed ID: 24281999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.